News & Publications

News

January 19, 2022

Ceptur Therapeutics Launches with $75M Series A Financing to Advance RNA Therapeutics Based on Proprietary U1 Adaptor Technology

Press

March 12, 2022

Ceptur Appoints Romesh Subramanian to Its Board of Directors and Expands R&D Operations in Copenhagen

Businesswire

January 19, 2022

A new startup wants to take antisense and siRNA one step further, and build more potent drugs than Ionis and Alnylam

Endpoint News

January 19, 2022

Bristol Myers, VCs launch new RNA therapeutics biotech Ceptur with $75M to silence pre-mRNA

Fierce Biotech

January 19, 2022

A new RNA-based drug startup launches with Rutgers science and money connections

STAT

January 19, 2022

Ceptur Launches U1 Adaptors with $75 Million Series A

BioSpace

January 19, 2022

Ceptur captures $75M series A for oligo approach

BioWorld

January 19, 2022

Genetic medicines developer that recently opened a Philadelphia lab raises $75M

Philadelphia Business Journal

Publications

September 22, 2021

U1 Adaptors Bioconjugates for Targeted Gene Silencing in Extrahepatic Tissues

Follow us or reach out on LinkedIn.